Semaphorin 4D (Sema4D/CD100) is a 150-kDa transmembrane glycoprotein expressed by platelets and T-cells. When these cells are activated, Sema4D is cleaved proteolytically, generating a biologically active 120-kDa fragment (soluble Sema4D) capable of targeting receptors on platelets, B-cells, endothelial cells and tumor cells. However, its plasma levels and significance in heart failure (HF) have not been reported. In this study, we established an ELISA and detected soluble Sema4D in human plasma. In healthy controls, plasma Sema4D levels were higher in men than women (5.15±3.30 ng/mL, n = 63, vs. 4.19±2.39 ng/mL, n = 63, P
Recommended CitationLu, Qiongyu; Dong, Ningzheng; Wang, Qi; Yi, Wenxiu; Wang, Yuxin; Zhang, Shengjie; Gu, Haibo; Zhao, Xin; Tang, Xiaorong; Jin, Boquan; Wu, Qingyu; Brass, Lawrence F; and Zhu, Li, "Increased levels of plasma soluble Sema4D in patients with heart failure." (2013). Department of Pharmacology and Experimental Therapeutics Faculty Papers. Paper 47.